Logo image of BTSG

BRIGHTSPRING HEALTH SERVICES (BTSG) Stock Fundamental Analysis

USA - NASDAQ:BTSG - US10950A1060 - Common Stock

29.355 USD
+1 (+3.51%)
Last: 10/13/2025, 2:17:02 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BTSG. BTSG was compared to 100 industry peers in the Health Care Providers & Services industry. BTSG has an average financial health and profitability rating. BTSG is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

BTSG had positive earnings in the past year.
BTSG had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BTSG reported negative net income in multiple years.
BTSG had a positive operating cash flow in 4 of the past 5 years.
BTSG Yearly Net Income VS EBIT VS OCF VS FCFBTSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.10%, BTSG is in line with its industry, outperforming 52.00% of the companies in the same industry.
BTSG has a Return On Equity (3.76%) which is in line with its industry peers.
BTSG has a Return On Invested Capital (4.19%) which is in line with its industry peers.
BTSG had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.33%.
The last Return On Invested Capital (4.19%) for BTSG is above the 3 year average (3.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.1%
ROE 3.76%
ROIC 4.19%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
BTSG Yearly ROA, ROE, ROICBTSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

BTSG has a Profit Margin (0.55%) which is comparable to the rest of the industry.
With a Operating Margin value of 1.96%, BTSG perfoms like the industry average, outperforming 49.00% of the companies in the same industry.
BTSG's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 12.88%, BTSG is doing worse than 69.00% of the companies in the same industry.
BTSG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.96%
PM (TTM) 0.55%
GM 12.88%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
BTSG Yearly Profit, Operating, Gross MarginsBTSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BTSG is destroying value.
Compared to 1 year ago, BTSG has more shares outstanding
The number of shares outstanding for BTSG has been increased compared to 5 years ago.
The debt/assets ratio for BTSG has been reduced compared to a year ago.
BTSG Yearly Shares OutstandingBTSG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
BTSG Yearly Total Debt VS Total AssetsBTSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 3.06 indicates that BTSG is not in any danger for bankruptcy at the moment.
The Altman-Z score of BTSG (3.06) is better than 61.00% of its industry peers.
The Debt to FCF ratio of BTSG is 13.29, which is on the high side as it means it would take BTSG, 13.29 years of fcf income to pay off all of its debts.
BTSG has a Debt to FCF ratio (13.29) which is in line with its industry peers.
A Debt/Equity ratio of 1.43 is on the high side and indicates that BTSG has dependencies on debt financing.
The Debt to Equity ratio of BTSG (1.43) is worse than 67.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 13.29
Altman-Z 3.06
ROIC/WACC0.48
WACC8.81%
BTSG Yearly LT Debt VS Equity VS FCFBTSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.76 indicates that BTSG should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.76, BTSG is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
A Quick Ratio of 1.34 indicates that BTSG should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.34, BTSG perfoms like the industry average, outperforming 49.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.34
BTSG Yearly Current Assets VS Current LiabilitesBTSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 130.29% over the past year.
Looking at the last year, BTSG shows a very strong growth in Revenue. The Revenue has grown by 20.60%.
BTSG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.01% yearly.
EPS 1Y (TTM)130.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120%
Revenue 1Y (TTM)20.6%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%15.29%

3.2 Future

Based on estimates for the next years, BTSG will show a very strong growth in Earnings Per Share. The EPS will grow by 38.52% on average per year.
BTSG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.46% yearly.
EPS Next Y72.44%
EPS Next 2Y47.13%
EPS Next 3Y39.08%
EPS Next 5Y38.52%
Revenue Next Year11.36%
Revenue Next 2Y11.85%
Revenue Next 3Y11.89%
Revenue Next 5Y12.46%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BTSG Yearly Revenue VS EstimatesBTSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
BTSG Yearly EPS VS EstimatesBTSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 0 1 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 39.67, BTSG can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as BTSG.
BTSG's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.02.
Based on the Price/Forward Earnings ratio of 24.66, the valuation of BTSG can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BTSG is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of BTSG to the average of the S&P500 Index (22.57), we can say BTSG is valued inline with the index average.
Industry RankSector Rank
PE 39.67
Fwd PE 24.66
BTSG Price Earnings VS Forward Price EarningsBTSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BTSG's Enterprise Value to EBITDA is on the same level as the industry average.
BTSG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 27.21
EV/EBITDA 17.64
BTSG Per share dataBTSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BTSG's earnings are expected to grow with 39.08% in the coming years.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y47.13%
EPS Next 3Y39.08%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BTSG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRIGHTSPRING HEALTH SERVICES

NASDAQ:BTSG (10/13/2025, 2:17:02 PM)

29.355

+1 (+3.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-31 2025-10-31/bmo
Inst Owners70.16%
Inst Owner Change0.57%
Ins Owners2.57%
Ins Owner Change-4.37%
Market Cap5.20B
Analysts84.21
Price Target30.01 (2.23%)
Short Float %16.35%
Short Ratio5.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)61.63%
Min EPS beat(2)26.26%
Max EPS beat(2)97.01%
EPS beat(4)2
Avg EPS beat(4)20.64%
Min EPS beat(4)-38.02%
Max EPS beat(4)97.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.05%
Min Revenue beat(2)2.86%
Max Revenue beat(2)3.24%
Revenue beat(4)3
Avg Revenue beat(4)2.58%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)4.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.47%
PT rev (3m)9.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.45%
EPS NY rev (1m)8.14%
EPS NY rev (3m)10.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.28%
Valuation
Industry RankSector Rank
PE 39.67
Fwd PE 24.66
P/S 0.43
P/FCF 27.21
P/OCF 19.37
P/B 2.98
P/tB N/A
EV/EBITDA 17.64
EPS(TTM)0.74
EY2.52%
EPS(NY)1.19
Fwd EY4.06%
FCF(TTM)1.08
FCFY3.68%
OCF(TTM)1.52
OCFY5.16%
SpS67.66
BVpS9.84
TBVpS-6.61
PEG (NY)0.55
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.1%
ROE 3.76%
ROCE 5.3%
ROIC 4.19%
ROICexc 4.26%
ROICexgc 12.79%
OM 1.96%
PM (TTM) 0.55%
GM 12.88%
FCFM 1.59%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexcg growth 3Y-9.4%
ROICexcg growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score7
Asset Turnover2.02
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 13.29
Debt/EBITDA 5.85
Cap/Depr 40.85%
Cap/Sales 0.65%
Interest Coverage 1.2
Cash Conversion 63.22%
Profit Quality 291.7%
Current Ratio 1.76
Quick Ratio 1.34
Altman-Z 3.06
F-Score7
WACC8.81%
ROIC/WACC0.48
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)130.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120%
EPS Next Y72.44%
EPS Next 2Y47.13%
EPS Next 3Y39.08%
EPS Next 5Y38.52%
Revenue 1Y (TTM)20.6%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%15.29%
Revenue Next Year11.36%
Revenue Next 2Y11.85%
Revenue Next 3Y11.89%
Revenue Next 5Y12.46%
EBIT growth 1Y172.04%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year60.02%
EBIT Next 3Y26.18%
EBIT Next 5Y28%
FCF growth 1Y186.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y284.83%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%